2 hours Zacks Research Issues Optimistic Outlook for FOLD EarningsMarketBeat
Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) – Research analysts at Zacks Research raised their Q3 2025 earnings estimates for Amicus Therapeutics in a research note issued to investors on Wednesday, October 16th. Zacks Research analyst R. …
Earnings · Nasdaq 100 · Science
X